Compositions for management of helicobacter pylori infections
US-2018344754-A1 · Dec 6, 2018 · US
Compositions and methods for management of atrophic gastritis and colitis
US11413318B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11413318-B2 |
| Application number | US-202016903989-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 17, 2020 |
| Priority date | Jun 6, 2017 |
| Publication date | Aug 16, 2022 |
| Grant date | Aug 16, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention discloses a method for therapeutic management of atrophic gastritis and colitis using a composition comprising Bacillus coagulans MTCC 5856 individually or in combination with anthocyanins. The invention further discloses a method for preventing neoplastic transformation of mucosal cells in gastro-intestinal tract and improving gut barrier function in mammals using a composition comprising Bacillus coagulans MTCC 5856 individually or in combination with anthocyanins.
First claim
Opening claim text (preview).
We claim: 1. A method of therapeutic management of atrophic gastritis in mammals, said method comprising a step of administering an effective amount of a composition comprising Bacillus coagulans MTCC 5856, to the mammal in need of therapy for atrophic gastritis. 2. The method as in claim 1 , wherein therapeutic management of atrophic gastritis is brought about by improving gut barrier function by restoration of normal architecture of gastric mucosa with intact gastric epithelial cells. 3. The method as in claim 1 , wherein, therapeutic management of atrophic gastritis is brought about by reducing inflammatory markers selected from the group consisting of IL-17A, IL-1β, and IL-6. 4. The method as in claim 1 , wherein therapeutic management of atrophic gastritis is brought about by reducing lipid peroxidation and oxidative stress. 5. The method as in claim 1 , wherein therapeutic management of atrophic gastritis is brought about by reducing elevated levels of enzyme myeloperoxidase. 6. The method as in claim 1 , wherein the effective amount is 150 mg/kg bodyweight of Bacillus coagulans MTCC 5856, equivalent to 2 billion spores. 7. The method as in claim 1 , wherein the mammal is human.
Assignees
Inventors
Classifications
- A61K31/352Primary
condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)} · CPC title
- A61K35/742Primary
Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes · CPC title
Drugs for disorders of the alimentary tract or the digestive system · CPC title
Probiotics · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11413318B2 cover?
- The present invention discloses a method for therapeutic management of atrophic gastritis and colitis using a composition comprising Bacillus coagulans MTCC 5856 individually or in combination with anthocyanins. The invention further discloses a method for preventing neoplastic transformation of mucosal cells in gastro-intestinal tract and improving gut barrier function in mammals using a com…
- Who is the assignee on this patent?
- Majeed Muhammed, Nagabhushanam Kalyanam, Bani Sarang, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/352. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).